Autopsy report · NCT01424033

A Clinical Trial for CTD-ILD Treatment

“Departure of study team”

The sponsor’s own words in the registry.

Life of this trial

• Registered 4 months before it started.
• 5 participants enrolled.
• Results were posted on the registry.

Vital statistics

Status

Terminated

Phase

Phase 2, Phase 3

Sponsor

University of Michigan

Sponsor type

University, hospital or other

Conditions

Interstitial Lung Disease; Connective Tissue Disease

Interventions

N-Acetylcysteine

Participants

5

Sites

1

Countries

United States

Trials that died the same way

• Bedside Assessment of Immune Function in Patients With Covid-19
  “Study team moved” (80% match in meaning)
• Hemostasis in Kocher-Langenbeck Approaches for Acetabular Surgery Using a Topical Surgical Hemostat (Vitagel)
  “Study team left institution; no one remaining to finish study” (78% match in meaning)
• Evaluation of Three Dimensional Echocardiography in Critical Care Medicine
  “Study team members moved away” (73% match in meaning)
• ROP Screening: Comparison of Pain Using Two Eyelid Retractors
  “Medical Leave of Absence of the Principal Investigator and study team changes” (72% match in meaning)
• The Impact of E-liquid Nicotine Content on Reinforcement in Current Smokers
  “Study team decided not to move forward with study” (71% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.